LOUISIANA ACADEMY OF EYE PHYSICIANS AND SURGEONS
Management of Neovascular Age-Related Macular Degeneration:
Improving Patient Outcomes
Wednesday, October 21, 2020
6:30 - 7:30 PM
VIRTUAL
The Louisiana Academy of Eye Physicians and Surgeons cordially invites you to attend a CME-certified live webinar entitled, Management of Neovascular Age-Related Macular Degeneration (nAMD): Improving Patient Outcomes, held live online! This activity is intended for ophthalmologists involved in the management of adults with nAMD and will help clinicians understand the latest nAMD advances and optimize patient outcomes.
Date: Wednesday, October 21, 2020
Time: 6:30 – 7:30 PM CT
Live Online!
For full accreditation information and to register, visit:
www.rockpointe.com/namdwebinar
There is no fee for this activity.
To receive CME credit, participants must register, view the live CME activity in its entirety and then complete the post-test, with a score of 66% or better and evaluation.
The estimated time for completion of this activity is one hour. Participants are allowed to take the post-test multiple times.
Disclosures will be made known to participants before the activity.
PROGRAM FACULTY
Benjamin V. Guidry, MD
Vitreoretinal Surgeon
Retina Consultants of New Orleans
Clinical Assistant Professor
Tulane University
New Orleans, Louisiana
ACCREDITATION
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Rockpointe. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
DESIGNATION STATEMENT
Boston University School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category I CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Jointly provided by Boston University School of Medicine and Rockpointe.
Supported by an independent educational grant from Novartis Pharmaceuticals Corporation